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pyrenophorol (PYR) impaired the function of human topo 
II, but did not show any effect on gyrase. The potency to 
inhibit topo II activity declined in the row STTX III (initial 
inhibitory concentration 10 µM) > AOH (25 µM) = AME 
(25 µM) = ALS (25 µM) = ATX II (25 µM) > ALN 
(50 µM) = ATX I (50 µM) > ALP (75 µM) = PYR 
(75 µM) > MAC (150 µM). Inhibition of gyrase activity 
was most pronounced for AOH and AME (initial inhibitory 
concentration 10 µM) followed by ATX II (25 µM) > ATX 
I = ALP = STTX III (50 µM). In contrast, none of the 
investigated Fusarium mycotoxins deoxynivalenol (DON), 
fumonisin B1, fusarin C and moniliformin, as well as the 
Alternaria metabolite tentoxin, had any impact on the 
activity of neither human nor bacterial topo II.
Keywords Topoisomerase II · Gyrase · Mycotoxins · 
Alternaria · Fusarium
Introduction
DNA-topoisomerases are essential enzymes that play a fun-
damental role in the maintenance of cellular DNA topol-
ogy, i.e., the integrity of DNA during replication or chro-
mosomal segregation (Champoux and Dulbecco 1972; 
DiNardo et al. 1984). According to their respective cata-
lytic mechanism of action, they are divided into type I and 
type II topoisomerases (Liu et al. 1980). The dimeric topoi-
somerase (topo) II acts as decatenase, introducing transient 
double-strand breaks into the DNA substrate, allowing the 
passage of an intact DNA double-strand and resealing the 
break afterward (Hsieh and Brutlag 1980; Liu et al. 1980). 
While a wanted effect in cancer therapy, the functional dis-
turbance of human topo II by food constituents may imply 
severe adverse effects (McClendon and Osheroff 2007).
Abstract Type II DNA-topoisomerases (topo II) play a 
crucial role in the maintenance of DNA topology. Previ-
ously, fungi of the Alternaria genus were found to pro-
duce mycotoxins that target human topo II. These results 
implied the question why a fungus should produce second-
ary metabolites that target a human enzyme. In the current 
work, the homology between human topo II and its bacte-
rial equivalent, gyrase, served as basis to study a potential 
dual inhibition of both enzymes by mycotoxins. A total of 
15 secondary metabolites produced by fungi of the genera 
Alternaria and Fusarium were assessed for their impact on 
topo II of human and bacterial origin in the decatenation 
and the supercoiling assay, respectively. In line with the 
theory of dual topo II inhibition, six of the tested Alternaria 
mycotoxins were active against both enzymes, the dibenzo-
α-pyrones alternariol (AOH) and alternariol monomethyl 
ether (AME), as well as the perylene-quinones altertoxin I 
(ATX I) and II (ATX II), alterperylenol (ALP) and stem-
phyltoxin III (STTX III). The Alternaria metabolites alter-
setin (ALN), macrosporin (MAC), altenusine (ALS) and 
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In previous studies, three secondary metabolites pro-
duced by food-contaminating fungi of the genus Alter-
naria, the dibenzo-α-pyrones AOH and AME, as well as 
the perylene-quinone ATX II, were found to inhibit the 
activity of human topo II in vitro (Fehr et al. 2009; Ties-
sen et al. 2013). Based on these results, the question arose 
what might prompt a mold to produce secondary metabo-
lites that target human enzymes. Since a fungus faces a 
variety of microorganisms within its habitat, against which 
it must compete, the formation of toxic secondary metabo-
lites that are detrimental to potential predators is discussed 
as defense method to ensure proper growth and propagation 
(Magan and Aldred 2007). The production of antibiotics is a 
mechanism of antibacterial defense that has been observed 
for many genera of fungi imperfecti, the most prominent 
being Aspergillus and Penicillium spp. (Lancini et al. 1995). 
A common target for antibiotic pharmaceuticals is gyrase, 
a bacterial topo II (Alt et al. 2011; Gellert et al. 1976b). 
Since gyrase shares a high degree of homology with human 
topo II, the previously observed interaction between Alter-
naria mycotoxins and human topo II was taken as indica-
tion of a potential dual inhibition. To consider this ques-
tion, 15 secondary metabolites produced by Alternaria 
and Fusarium fungi were investigated for their effect on 
the activity of topo II of both human and bacterial origin. 
These molds grow as endophytes on host plants worldwide, 
contaminating a variety of food and feed (Kharwar et al. 
2014; Placinta et al. 1999). The two fungi genera synthe-
size chemically very diverse secondary metabolites, as can 
be seen with an exemplarily selection in Fig. 1. Some of 
the tested Alternaria mycotoxins share structural features, 
for instance the perylene-quinone-type toxins ATX I, ATX 
II, ALP and STTX III (Fig. 1a), which differ by an epoxy 
group and/or a double bond. The dibenzo-α-pyrones AOH 
Fig. 1  Chemical structures of secondary metabolites produced by 
Alternaria and Fusarium fungi. Molecules are grouped according 
to structure and producing organisms in a perylene-quinone-type, 
b dibenzo-α-pyrones both from Alternaria and c other Alternaria 
mycotoxins, d four secondary metabolites produced by Fusarium spp
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and AME (Fig. 1b), also produced by Alternaria fungi, dis-
tinguish themselves only by a methyl group. The further 
Alternaria metabolites that were assessed in this study con-
stitute a chemically heterogeneous group, composed of the 
macrodiolide PYR, the anthraquinone MAC, the tetrapep-
tide TEN, the tetramic acid derivative ALN and the biphe-
nyl ALS (Fig. 1c). The investigated Fusarium metabolites 
include the trichothecene DON, the polyketide FB1, which 
is characterized by an eicosane backbone, the sesquiterpe-
noid FC and the semiquadric acid MON (Fig. 1d). In the 
present work, these 15 secondary fungal metabolites were 
investigated for their potential interference with type II 
topoisomerases of human and bacterial origin in cell-free 
experimental setups. Since most of the selected perylene-
quinones are not commercially available, these compounds 
were isolated from rice inoculated with Alternaria alter-
nata cultures.
Experimental procedures
Cell culture and fungus cultivation
The human colon adenocarcinoma cell line HT29 and the 
Alternaria alternata strain DSM 62010 were obtained from 
the German Collection of Microorganisms and Cell Cul-
tures GmbH (DSMZ, Braunschweig, Germany). Cells were 
cultured in Dulbecco’s modified Eagle medium (DMEM; 
GIBCO Invitrogen, Karlsruhe, Germany) supplemented 
with 10 % FBS and 1 % P/S and maintained in incubators 
at 37 °C and 5 % CO2. Cultivation of the Alternaria strains 
was performed on moist, autoclaved rice, as described pre-
viously (Schwarz et al. 2012b).
Isolation and identification of Alternaria 
perylene‑quinone‑type mycotoxins from inoculated rice 
cultures
Due to lack of commercially available ATX I, ATX II, ALP 
and STTX III, the toxins were isolated from Alternaria-
infested rice. Ethyl acetate extracts were prepared after 
21 days of incubation from rice which was inoculated with 
Alternaria alternata strain DSM 62010 as described in 
Schwarz et al. (2012a). Fractionation of the ethyl acetate 
extracts by solid-phase extraction (SPE) and isolation of 
the toxins with HPLC were conducted according to Jarolim 
et al. (2016). For isolation individual fractions were col-
lected, concentrated under reduced pressure (40 °C), and 
freeze-dried in duplicate, yielding ATX II and STTX III 
in high purities (>97 % HPLC–UV, 270 nm). ATX I and 
ALP were re-purified using the HPLC system and col-
umn mentioned in Jarolim et al. (2016) and the following 
gradient. Monitoring the effluent (4.2 ml/min) at 350 nm, 
chromatography was performed starting with a mixture 
(80/20, v/v) of aqueous formic acid (0.1 % in H2O) and 
MeCN, the MeCN content was increased to 45 % within 
16 min and to 70 % within 4 min, followed by column 
washing and re-equilibration. Individual fractions were col-
lected, concentrated under reduced pressure (40 °C), and 
freeze-dried in duplicate, yielding ATX I and ALP (>97 % 
HPLC–UV, 270 nm).
Aliquots of the isolated fractions were analyzed by 
means of UPLC–TOF–MSe on a Waters Synapt G2-S 
HDMS mass spectrometer (Waters, Manchester, UK) cou-
pled to an Acquity UPLC core system (Waters, Milford, 
MA, USA) equipped with a 2 × 150 mm, 1.7 µm, BEH 
C18 column (Waters, Manchester, UK) consisting of a 
binary solvent manager, sample manager and column oven. 
Operated with a flow rate of 0.4 ml/min at 50 °C, the fol-
lowing gradient was used for chromatography: Starting 
with a mixture (10/90, v/v) of aqueous formic acid (0.1 % 
in H2O) and MeCN (0.1 % formic acid), the MeCN con-
tent was increased to 100 % within 4 min and, then, kept 
constant for 0.5 min. Scan time for the MSe method (cen-
troid) was set to 0.1 s. Analyses were performed in the 
negative ESI and the high-resolution mode using the fol-
lowing ion source parameters: capillary voltage −2.5 kV, 
sampling cone 30 V, source offset 20 V, source temperature 
150 °C, desolvation temperature 450 °C, cone gas 30 l/h, 
nebuliser 6.5 bar and desolvation gas 850 l/h. Data pro-
cessing was performed by using MassLynx 4.1 SCN 9.16 
(Waters, Manchester, UK) and the elemental composition 
tool for determining the accurate mass. All data were lock 
mass corrected on the pentapeptide leucine enkephaline 
(Tyr-Gly-Gly-Phe-Leu, m/z 554.2615, [M–H]−) in a solu-
tion (1 ng/µl) of MeCN/0.1 % formic acid (1/1, v/v). Scan 
time for the lock mass was set to 0.3 s, an interval of 15 s 
and 3 scans to average with a mass window of ±0.3 Da. 
Calibration of the Synapt G2-S in the range from m/z 50 
to 1200 was performed using a solution of sodium formi-
ate (5 mmol/l) in 2-propanol/H2O (9/1, v/v). The UPLC 
and Synapt G2-S systems were operated with MassLynx™ 
software (Waters).
All 1D and 2D NMR measurements (1H, 1H-1H-gCOSY, 
gHSQC, gHMBC and 13C) were performed on an Avance 
III 500 MHz spectrometer with a CTCI probe (Bruker, 
Rheinstetten, Germany).
ATX I was identified by UPLC-ESI-TOF-MS and 
NMR as previously described in Jarolim et al. (2016). The 
structure of the isolated ATX II was described in detail by 
Schwarz et al. (2012b). ATX II was identified with an m/z 
of 349.0714 ([M–H]−, calculated for C20H13O6, 349.0712, 
+0.6 ppm) in the (–) HRESIMS. Data of the 1H NMR and 
13C NMR of ALP and STTX III are summarized in the sup-
plementary information (Tables S2–S5) and were in line to 
Hradil et al. (1989); and Stack and Prival (1986). ALP was 
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identified with an m/z of 349.0714 ([M-H]−, calculated for 
C20H13O6, 349.0712, +0.6 ppm) in the (–) HRESIMS m/z. 
1H NMR and 13C NMR data are summarized in appendix 
and in line to Hradil et al. (1989); and Okuno et al. (1983). 
STTX III was identified with an m/z of 347.0557 ([M–H]−, 
calculated for C20H11O6, 347.0556, +0.3 ppm) in the (–) 
HRESIMS. 1H NMR and 13C NMR data of ALP and STTX 
III are summarized in the electronic supplementary infor-
mation (Tables S1–S5) and were in line to Stack and Maz-
zola (1989).
Secondary metabolites from Alternaria and Fusarium 
spp.
The Alternaria dibenzo-α-pyrones AOH and AME and the 
Fusarium trichothecene DON were bought from Sigma–
Aldrich (MI, USA). Macrosporin, tentoxin, altenusin and 
pyrenophorol were obtained from Enzo Life Sciences 
(Lausen, Switzerland). Altersetin was purchased from Ana-
lytiCon Discovery GmbH (Potsdam, Germany). FB1 and 
FC were isolated from Fusarium verticillioides MRC 826 
and Fusarium verticillioides MRC 0712 as described in the 
literature (Hübner et al. 2012; Kleigrewe et al. 2011). MON 
was synthesized according to Lohrey et al. (2011).
Decatenation assay
The interference of the tested secondary fungal metabo-
lites with human topoisomerase II α was determined using 
the decatenation assay. Briefly, this assay is based on the 
measurement of the ability of topo II α enzyme to decat-
enate a fragment of catenated kDNA. The topo II poison 
and anticancer drug etoposide was used as positive con-
trol (Ross et al. 1984). A gel with 1 % agarose (w/v) was 
prepared using tris–acetate-EDTA (TAE) puffer contain-
ing 20 mM tris, 1 mM EDTA and 9.6 mM acetic acid. The 
reaction mixture with a final volume of 20 µl contained 
0.5 U human topoisomerase II α, 200 ng kDNA, the test 
substance with a solvent concentration of 5 % EtOH (in 
case of perylene-quinones due to better stability) or DMSO 
and complete Topo II Assay Buffer from TopoGEN. The 
solution was allowed to react for 1 h at 37 °C, and the reac-
tion was stopped on ice by adding loading buffer (25 % 
glycerol, 0.125 % bromphenolblue) with 5 % N-lauroyl-
sarkosin. For dyeing of DNA bands, the gel was incubated 
for 20 min with 10 mg/l ethidium bromide solution. For 
quantification purposes, the fluorescence intensities of the 
decatenated kDNA bands at the lower end of the gels were 
used. The fluorescence signal was detected with the Image-
Quant LAS-4000 (GE Healthcare Life Sciences, Bucking-
hamshire, England). Catenated DNA was quantified using 
Fujifilm Image Gauge software (Fujifilm Medical Sys-
tems USA, Inc., Connecticut, USA). For quantification the 
fluorescence intensities were normalized to solvent control 
(=100 %).
Gyrase supercoiling assay
The secondary metabolites were tested for their potential 
impact on the activity of the bacterial topo II gyrase with 
the gyrase supercoiling assay, where the difference in 
mobility between relaxed and supercoiled closed circular 
pUC19 was used (Gellert et al. 1976a). Gyrase from E. coli 
and relaxed 2686-bp-long puUC19 were purchased from 
New England Biolabs (Frankfurt am Main, Germany). A 
gel with 1 % agarose (w/v) was prepared using tris-acetat-
EDTA (TAE) puffer containing 20 mM Tris, 1 mM EDTA 
and 9.6 mM acetic acid. Reaction mixture for determina-
tion of gyrase inhibition with a final volume of 20 µl con-
tained 0.5 U gyrase, 250 ng pUC19, 35 mM Tris HCl (pH 
7.5), 24 mM KCl, 4 mM MgCl2, 2 mM DTT, 1.75 mM 
ATP, 5 mM spermidine, 0.1 mg/ml BSA and 6.5 % glyc-
erol. The solution was allowed to react for 60 min at 37 °C, 
and the reaction was stopped on ice by adding loading 
buffer (25 % glycerol, 0.125 % bromphenolblue) with 5 % 
N-lauroylsarkosin. For dyeing of DNA bands, the gel was 
incubated for 20 min with 10 mg/l ethidium bromide solu-
tion. The fluorescence signal was detected with the Image-
Quant LAS-4000 (GE Healthcare Life Sciences, Bucking-
hamshire, England). Catenated DNA was quantified using 
Fujifilm Image Gauge software (Fujifilm Medical Systems 
USA, Inc., Connecticut, USA). Activity of gyrase was 
assessed according to mobility shifts in the DNA pattern 
on the gel. Relaxed pUC19 demonstrated a lower migrat-
ing distance in the gel compared to the supercoiled ana-
logue which was generated in case of active gyrase. The 
aminocoumarin antibiotic novobiocin (50 µM) was used 
as positive control (Gellert et al. 1976b). Quantification of 
the DNA bands via fluorescence intensity, as performed in 
the decatenation assay, was not applicable for this method 
because of the high degree of band multiplicity, presumably 
due to topoisomeres. Hence, the quantification was done by 
evaluating the observed initial inhibitory concentrations on 
the gels of at least three independent experiments and an 
average initial inhibitory concentration was calculated.
Results
Assessment of the impact of selected secondary 
metabolites from Alternaria and Fusarium spp. on the 
activity of human topo II α
The effect of 15 secondary metabolites of Alternaria and 
Fusarium fungi on the activity of human topo II α was 
evaluated with the decatenation assay (Table 1). Incubation 
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of human topo II α and kDNA for 1 h in the presence of 
all four Alternaria perylene-quinone-type mycotoxins 
decreased the activity of the enzyme in a concentration-
dependent manner (Fig. 2). ATX I led to a significant 
decrease at 50 µM and was thus a weaker inhibitor than 
ATX II, for which an initial inhibitory concentration of 
25 µM was observed. ALP, which showed the weakest 
impact on topo II α of the four compounds, significantly 
decreased topo II α activity at 75 µM. The most potent 
inhibitor in the decatenation assay was STTX III with 
an initial inhibitory concentration of 10 µM. Of the fur-
ther five Alternaria metabolites tested in this assay, ALN, 
MAC, ALS, PYR (Fig. 3) and TEN (Fig. 4), the first four 
also showed inhibitory effects on human topo II α. Among 
these, ALS had the highest potency to suppress topo II-
mediated decatenation with an initial inhibitory concentra-
tion of 25 µM, thus comparable to ATX II. According to the 
initial inhibitory concentrations in the decatenation assay, 
the potency for topo II inhibition declined in the row STTX 
III (10 µM) > ALS (25 µM) = ATX II (25 µM) > ALN 
(50 µM) = ATX I (50 µM) > ALP (75 µM) = PYR 
(75 µM) > MAC (150 µM). Of the four Fusarium metabo-
lites that were examined, FB1, MON, DON and FC, none 
was tested positive for inhibition of the decatenating activ-
ity of topo II α up to a concentration of 150 µM (Fig. 4).
Assessment of the impact of selected secondary 
metabolites from Alternaria and Fusarium spp. on the 
activity of bacterial gyrase
In order to evaluate if the effects on human topo II were 
reflected with respect to interference with the bacterial 
homologue, the impact of the substances on gyrase from 
E. coli was measured with the gyrase supercoiling assay. 
This gel-based assay allows an estimation of a substance’s 
inhibitory potential by assessing the migration of the plas-
mid pUC19, which is converted from the relaxed topoi-
somere to the more condensed and thus faster migrating 
supercoiled form by active gyrase. In Fig. 5 four exemplary 
gels are depicted of the three active Alternaria metabo-
lites ATX I, AOH and AME, which reduced the supercoil-
ing activity of gyrase to different extents, as well as the 
Fusarium mycotoin FB1, which did not show any targeting 
of gyrase. All four perylene-quinones, ATX I, ATX II, ALP 
and STTX III, impaired the activity of the enzyme (Fig. 6a). 
None of the other tested compounds, neither Alternaria 
nor Fusarium metabolites, had any effect on the activity of 
gyrase (Fig. 6b, c). Lane 1 of each gel represents the relaxed 
DNA plasmid, pUC19, without addition of enzyme or toxin, 
in lane 2 the respective solvent (DMSO) and gyrase were 
added. Lanes 3–8 and 3–19 show the addition of the tested 
compounds in a concentration range from 1 µM to 100 µM. 
Novobiocin (50 µM) was used as positive control (Figs. 5, 
lane 9, 6, lane 15). The conversion from the initially relaxed 
DNA plasmid to the supercoiled form catalyzed by gyrase 
can be seen when comparing lanes 1 (without gyrase) and 2 
(with gyrase). With increasing concentrations of each of the 
active toxins, ATX I, ATX II, ALP, STTX III, AOH or AME, 
a shift from the supercoiled plasmid to the relaxed form was 
observable, indicative for an inhibition of the supercoiling 
activity of gyrase. The most pronounced inhibitory effects 
on gyrase activity were observed for the dibenzo-α-pyrones, 
AOH and AME (initial inhibitory concentrations of 10 µM), 
followed by the altertoxin ATX II (25 µM) and ATX I, ALP 
and STTX III (50 µM; Table 1).
Discussion
Topo II plays an important role in the maintenance and 
alteration of the topological structure of DNA in the course 
of cellular processes like replication or chromosomal seg-
regation. Due to its involvement in this broad range of 
Table 1  Effect of Alternaria and Fusarium toxins of the activity of 
type IIA topoisomerases human topo II α and bacterial gyrase
Effects of mycotoxins on human recombinant topo II α (h topo II α) 
and bacterial gyrase based on at least three independent experiments 
(initial inhibition at: 10 µM (+++++), 25 µM (++++), 50 µM 
(+++), 75 µM (++) and 150 µM (+); no inhibition up to 150 µM 
(–))
a Fehr et al. (2009)
Initial inhibitory conc. (μM)
h topo II α Gyrase
Alternaria spp.
 Perylene chinones
  ATX I ++ +++
  ATX II ++++ ++++
  ALP ++ +++
  STTX III +++++ +++
 Dibenzo-α-pyrones
  AOH ++++a +++++
  AME ++++a +++++
 Others
  ALN +++ –
  ALS ++++ –
  PYR +++ –
  MAC – –
  TEN – –
Fusarium spp.
 FB1 – –
 FC – –
 MON – –
 DON – –
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vital biological processes, compounds that interfere with 
the proper function of the enzyme pose a potential health 
threat. Previously three mycotoxins produced by the 
endophytic mold of the genus Alternaria, the perylene-
quinone derivative ATX II and the dibenzo-α-pyrones AOH 
and AME, have been described to affect the function of 
Fig. 2  Impact of Alternaria 
mycotoxins ATX I, ATX II, ALP 
and STTX III on the activity of 
human topo II α in the decat-
enation assay. Depicted are the 
fluorescence intensities of the 
catenated kDNA, normalized to 
solvent control (5 % EtOH) and 
representative gels. Bars refer to 
mean values ± standard devia-
tion of at least three independ-
ent experiments. Significance 
levels refer to comparison 
with the respective smallest 
concentration of each substance 
***p < 0.001, **p < 0.01, 
*p < 0.5)
Fig. 3  Impact of Alternaria 
mycotoxins ALN, MAC, ALS 
and PYR on the activity of 
human topo II α in the decat-
enation assay. Depicted are the 
fluorescence intensities of the 
catenated kDNA, normalized to 
solvent control (5 % EtOH) and 
representative gels. Bars refer to 
mean values ± standard devia-
tions of at least three independ-
ent experiments. Significance 
levels refer to comparison 
with the respective smallest 
concentration of each substance 
***p < 0.001, **p < 0.01, 
*p < 0.5)
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human topo II (Fehr et al. 2009; Tiessen et al. 2013). These 
results opened a wider research field focused on the effect 
of fungal secondary metabolites on this important enzyme 
family. In the present work, 15 secondary metabolites, 11 
of which are produced by Alternaria spp. and 4 by Fusar-
ium spp., were investigated for their effects on human topo 
II α (Fig. 1). Except for TEN, all the secondary Alternaria 
metabolites inhibited the activity of human topo II α in the 
decatenation assay in a concentration range between 1 and 
150 µM (Figs. 2, 3, 4). Within these ten topo II-targeting 
metabolites, no correlation between structural character-
istics and inhibition potential was observable, except for 
the Alternaria perylene-quinone derivatives. Of the four 
assessed compounds that belong to this class, ATX II and 
STTX III revealed the most pronounced impact on the 
activity of human topo II α. Both mycotoxins contain an 
epoxide group, whereas their structural analogues ATX 
I and ALP, weaker inhibitors, lack this moiety (Fig. 1a). 
The correlation between the presence of an epoxide and, 
as a consequence thereof, an enhancement of the respec-
tive inhibitory potential was restricted to human topo II α 
within the perylene-quinones, since the activity of bacte-
rial gyrase was reduced most effectively by the altertoxins 
ATX I and ATX II, with the same potency. Interestingly, the 
Fig. 4  Impact of secondary 
metabolites of Fusarium spp. 
on the activity of human topo 
II α in the decatenation assay. 
Depicted are representative gels 
of DON (lanes 1–3), FB1 (lanes 
6–8), TEN (lanes 9–11), FC 
(lanes 12–14) and MON (lanes 
15–17) with concentrations of 
1, 50 and 100 µM each. Etopo-
side (50 µM) served as positive 
control (lanes 4, 5)
Fig. 5  Impact of second-
ary metabolites produced by 
Alternaria and Fusarium fungi 
on bacterial gyrase. Effect of a 
Alternaria perylene-quinone-
type mycotoxin ATX I and 
dibenzo-α-pyrone AME and of 
b Alternaria mycotoxin AOH 
and Fusarium mycotoxin FB1 
on the supercoiling activity of 
bacterial gyrase. Lane 1 relaxed 
pUC19 without gyrase, lane 2 
addition of 0.5 U gyrase, lanes 
3–8 gyrase and toxins in the 
concentration range 1–100 µM 
in solvent (5 %), lane 9 gyrase 
and novobiocin as positive 
control
2014 Arch Toxicol (2017) 91:2007–2016
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Fusarium mycotoxin DON, also equipped with an epoxy 
moiety (Fig. 1d), did not show any impact on either human 
nor bacterial enzyme, possibly due to steric hindrance of 
the epoxide. Comparison of the two benzo-α-dipyrones, 
AOH and AME, which are structurally alike except for the 
additional methyl group in case of AME, showed that this 
moiety did not affect the inhibitory potency toward topo II 
(Fig. 1b). In line with these findings, AOH was previously 
described not only to suppress topo II activity under cell-
free conditions but also to act as a topo II poison in intact 
cells, stabilizing the covalent topo-II-DNA intermediate 
(Fehr et al. 2009). In contrast, ATX II, also potent under 
cell-free conditions, did not affect the intracellular levels of 
the covalent topo-II-DNA intermediate, indicating a func-
tion as a catalytic inhibitor (Tiessen et al. 2013).
The impact on the activity of human topo II α, which 
was observed for 10 out of 15 tested secondary metabolites 
from Alternaria spp. in the decatenation assay, raised the 
question whether this mechanism was restricted to com-
pounds produced by this genus. As an initial orientating 
study, considering the amount of known mycotoxins, four 
Fusarium metabolites out of different structural classes 
(FB1, MON, DON and FC; Fig. 1d) were examined for 
their effect on human topo II α. Of note, none of the tested 
Fusarium metabolites showed any interference with the 
enzyme (Fig. 4). Thus, the inhibition of topo II α seemed 
to be restricted to the secondary metabolites produced by 
Alternaria spp.
The present results indicated a common effect of inhi-
bition of topo II by the tested secondary metabolites pro-
duced by Alternaria spp. Since topo II is an enzyme family 
ubiquitous not only in mammals, but plays a vital role in 
prokaryotes as well, the targeting of topo II by the second-
ary fungal metabolites may be based on a potential dual 
inhibition of the human enzyme and its bacterial homo-
logue (Champoux 2001; McClendon and Osheroff 2007). 
In general, the biosynthesis of substances which interfere 
with cellular targets of potential predators, that are essen-
tial for survival in the food chain, is a mechanism that was 
described for other fungi imperfecti, as for instance the 
production of antibiotics by Penicillium or Aspergillus spp. 
(Lancini et al. 1995). Indeed, the bacterial topo II, gyrase, 
Fig. 6  Impact of second-
ary metabolites produced by 
Alternaria and Fusarium fungi 
on bacterial gyrase. a The per-
ylene-quinone derivatives ATX I 
(lanes 3–5), ATX II (lanes 6–8), 
ALP (lanes 9–11) and STTX 
III (lanes 12–14), b Alternaria 
metabolites ALN (lanes 2–4), 
PYR (lanes 8–10), ALS (lanes 
11–13), MAC (lanes 14–16) 
and TEN (lanes 17–19). In c 
gels of FB1 (lanes 3–5), FC 
(lanes 6–8), MON (lanes 9–11) 
and DON (lanes 12–14) are 
depicted. Novobiocin (50 µM) 
was used as positive control
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is a target of many classes of pharmaceutical antibiotics 
(Gellert et al. 1976b). In line with this theory, investiga-
tions of the impact of the tested secondary metabolites on 
gyrase from E. coli revealed that some of the tested second-
ary metabolites showed an effect on both the human and 
bacterial topo II, while other substances were only active 
against the human enzyme (Table 1). The compounds that 
suppressed both the human and the bacterial analogue were 
the perylene-quinone-type mycotoxins and the dibenzo-α-
pyrones from Alternaria spp. These results support our the-
ory that the impairment of the function of human topo II by 
secondary fungal metabolites may be attributed to the high 
degree of homology between human and bacterial enzyme. 
This implies that gyrase probably constitutes the main 
target of Alternaria spp., but their secondary metabolites 
affect human topo II as well. Such a dual targeting of topoi-
somerases was reported for other compounds, for instance 
the coumarin novobiocin, which targets mammalian as well 
as prokaryotic topo II (Larsen et al. 2003). Furthermore, 
several novel quinolone derivatives were shown to be active 
against both bacterial gyrase and its homolog, also of bac-
terial origin, the tetrameric topoisomerase IV (Mitton-Fry 
et al. 2013).
To the best of our knowledge, so far no data about the 
antibacterial activity of the perylene-quinones or the 
dibenzo-α-pyrones tested in this study have been published. 
On the contrary, antibiotic effects were described for some 
of the metabolites that inhibited human topo II α but not 
gyrase, to which ALN, ALS, PYR and MAC belong (Fig. 2; 
Table 1). Antibiotic properties of ALN toward gram-posi-
tive bacteria were reported previously, while gram-negative 
ones, among which E. coli are counted, were not affected 
(Schobert and Schlenk 2008). Furthermore, bacteria pos-
sess a second topo II aside from gyrase, topoisomerase IV, 
which also represents a target of antibiotics (Kato et al. 
1990; Khodursky et al. 1995). Although gyrase and topo 
IV share a high degree of homology, antibacterial agents 
differ in their sensitivity toward the two enzymes (Hooper 
1999; Pommier et al. 2010; Takei et al. 2001). Hence, it is 
possible to speculate that the compounds that did not affect 
gyrase, but were active against human topo II, may poten-
tially target topo IV. This specificity for topo IV was also 
reported for the glycosylated flavonoid quercetin (Bernard 
et al. 1997). ALS, which inhibited human topo II but not 
gyrase, might also target topo IV, since the substance was 
previously reported to decrease the growth of a spectrum of 
pathogenic bacteria (Kjer et al. 2009).
Only one of the Alternaria metabolites, the phytotoxin 
TEN, and all 4 tested Fusarium compounds did not reveal 
an inhibitory potency against either human or bacterial topo 
II (Halloin et al. 1970). Interestingly, antibacterial charac-
teristics were described for DON in Streptococcus agalac-
taie, but not E. coli (Ali-Vehmas et al. 1998). Presumably 
the mechanism of action behind the reported antibacte-
rial characteristics was not topo II-related. Generally, the 
impairment of topo II seemed to be limited to the second-
ary metabolites from Alternaria spp. that were tested in this 
study, whereas the Fusarium mycotoxins did not show any 
effect on this enzyme, neither on the human nor on the bac-
terial one.
In conclusion, 10 out of 15 secondary metabolites pro-
duced by Alternaria spp., evaluated for their impact on 
human topo II in the present work, revealed an inhibitory 
potential. Additionally, the perylene-quinone derivatives 
and the dibenzo-α-pyrones were also active against the bac-
terial homologue, gyrase, which indicated a dual inhibition 
of human as well as bacterial topo II. In contrast, none of 
the tested Fusarium metabolites revealed any interference 
with either human topo II or gyrase. With respect to food 
safety, interference with topo II apparently has to be con-
sidered as a potential genotoxic mechanism for a broader 
spectrum of Alternaria metabolites. On the other hand, in 
medicinal chemistry, topo II inhibition is a well-used drug 
effect in cancer therapy. Moreover, targeting of bacterial 
gyrase is a promising feature toward the identification of 
novel antibiotic structures. Considering the broad spectrum 
of secondary metabolites formed by Alternaria spp. and the 
already identified structures with activity toward human 
topo II and bacterial gyrase, it is likely to speculate that 
Alternaria secondary metabolites might represent a promis-
ing pool for the identification of compounds with pharma-
ceutical potency.
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